TipRanks
COMPASS Pathways (CMPS)
NASDAQ:CMPS
US Market
CMPS
COMPASS Pathways
RESEARCH TOOLSreports
Want to see CMPS full AI Analyst Report?

COMPASS Pathways (CMPS) Stock News & Sentiment

2,617 Followers
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
Premium
Ratings
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
21d ago
CMPS
Compass Pathways Advances Redefine PTSD Trial, Keeping Psychedelic Therapy Hopes Alive
Premium
Company Announcements
Compass Pathways Advances Redefine PTSD Trial, Keeping Psychedelic Therapy Hopes Alive
27d ago
CMPS
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
Premium
Company Announcements
Compass Pathways (CMPS) Earnings Call Highlights COMP360’s Path
1M ago
CMPS
Ritu Baral Reiterates Buy on COMPASS Pathways as COMP360 Advances Toward 2027 Launch with Strong Cash Runway
Premium
Ratings
Ritu Baral Reiterates Buy on COMPASS Pathways as COMP360 Advances Toward 2027 Launch with Strong Cash Runway
2M ago
CMPS
Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts
Premium
Weekend Updates
Wells Fargo, BKR, SLB, HAL, CMPS Trending With Analysts
3M ago
BKR
HAL
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
Premium
Ratings
Analyst Reaffirms Buy on CMPS, Viewing Post-Data Pullback as Entry Opportunity Ahead of 1H27 Launch
3M ago
CMPS
Compass Pathways reports positive Phase 3 depression results
Premium
Company Announcements
Compass Pathways reports positive Phase 3 depression results
3M ago
8K
CMPS
More CMPS News >

CMPS News on the Web

Compass Pathways PLC at TD Cowen Novel Mechanisms in Neuropsychiatry Conference (Virtual) Transcript
GuruFocus News
Neutral
Compass Pathways PLC at Deutsche Bank HealthCare Summit Transcript
GuruFocus News
Neutral
Compass Pathways PLC at Morgan Stanley Global Healthcare Conference Transcript
GuruFocus News
Neutral
Psychedelic: Optimi to initiate Phase 2 trial of psilocybin-assisted therapy
TipRanks News
Bullish
COMPASS Pathways: Strong Phase 3 TRD Data, Differentiated Positioning Support Unchanged $24 Price Target and Buy Rating
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: SOPHiA GENETICS (SOPH) and COMPASS Pathways (CMPS)
TipRanks News
Neutral
COMPASS Pathways (CMPS) Q2 2026 Earnings Call Transcript
The Motley Fool
Neutral
Analysts’ Top Healthcare Picks: COMPASS Pathways (CMPS), Trulieve Cannabis (TRLV)
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CMPS
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CMPS’s Media Buzz Sentiment?
1 articles about CMPS were published this week. In an average week, 3.25 articles are published.
    What is CMPS’s weekly average amount of articles?
    In an average week, 3.25 articles about CMPS are published.
      What is CMPS’s News Sentiment?
      100% of articles about CMPS were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        SMMTSummit Therapeutics
        CDNACareDx
        ARGXArgenx Se
        MEOBFMesoblast Limited
        KODKodiak Sciences
        Showing the stocks with the most bullish news sentiment over the past week